Expression of Epstein-Barr virus latent membrane proteins leads to changes in keratinocyte cell adhesion

被引:15
|
作者
Farwell, DG
McDougall, JK
Coltrera, MD
机构
[1] Univ Washington, Dept Otolaryngol Head & Neck Surg, Sch Med, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
关键词
cell adhesion molecules; Epstein-Barr virus; immunocytochemistry; latent membrane proteins;
D O I
10.1177/000348949910800906
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Epstein-Barr virus (EBV) has 3 latent membrane proteins (LMPs)- LMP1, LMP2a, and LMP2b - which are expressed in nasopharyngeal carcinoma. Using keratinocyte cell lines expressing LMP2a and LMP2b and coexpressing LMP1/LMP2a, we grew organotypic raft cultures to analyze changes in morphology and expression of the cell adhesion molecule ICAM-1; alpha 2, alpha 3, alpha 5, beta 1, and alpha 6 beta 4 integrins; laminin 5; E-cadherin; and desmoplakin. Cells expressing LMP2a or LMP2b were defective in their ability to mature and progress through normal squamous stratification when compared to the parental cell lines. Cells coexpressing LMP1/LMP2a additionally demonstrated "pseudoinvasion" into the raft dermal equivalent. There was a consistent and dramatic up-regulation in the suprabasal expression of laminin 5 and alpha 6 beta 4 and beta 1 integrins in the LMP-expressing cell lines. ICAM-1, not expressed in the control cell lines, was up-regulated in the LMP-expressing cell lines. Expression of alpha 3 and alpha 5 integrins was also up-regulated in the LMP-expressing cell lines, while alpha 2 demonstrated a loss of the normal basal layer expression. E-cadherin and desmoplakin expression patterns were essentially unchanged. We conclude that LMP2a and LMP2b singly, and LMP1/LMP2a coexpressed, are capable of altering keratinocyte cell adhesion molecule expression consistent with nasopharyngeal carcinoma.
引用
收藏
页码:851 / 859
页数:9
相关论文
共 50 条
  • [1] Expression of latent membrane proteins in Epstein-Barr virus-transformed lymphocytes in vitro
    Tang, Yunlian
    Luo, Chunyan
    Cheng, Ailan
    Lu, Suli
    Xu, Jinhua
    Fu, Ting
    Gan, Runliang
    MOLECULAR MEDICINE REPORTS, 2014, 10 (02) : 1117 - 1121
  • [2] The expression and function of Epstein-Barr virus encoded latent genes
    Young, LS
    Dawson, CW
    Eliopoulos, AG
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2000, 53 (05): : 238 - 247
  • [3] Expression of Epstein-Barr virus (EBV)-encoded latent membrane proteins and STAT3 activation in nasopharyngeal carcinoma
    Buettner, Maike
    Heussinger, Nicole
    Niedobitek, Gerald
    VIRCHOWS ARCHIV, 2006, 449 (05) : 513 - 519
  • [4] Epstein-Barr virus latent membrane protein 1: Structure and functions
    Li, HP
    Chang, YS
    JOURNAL OF BIOMEDICAL SCIENCE, 2003, 10 (05) : 490 - 504
  • [5] RECK is a target of Epstein-Barr virus latent membrane protein 1
    Liu, LT
    Peng, JP
    Chang, HC
    Hung, WC
    ONCOGENE, 2003, 22 (51) : 8263 - 8270
  • [6] Epstein-Barr virus latent and replicative gene expression in gastric carcinoma
    Selves, J
    Bibeau, F
    Brousset, P
    Meggetto, F
    Mazerolles, C
    Voigt, JJ
    Pradere, B
    Chiotasso, P
    Delsol, G
    HISTOPATHOLOGY, 1996, 28 (02) : 121 - 127
  • [7] Vaccination against Epstein-Barr Latent Membrane Protein 1 Protects against an Epstein-Barr Virus-Associated B Cell Model of Lymphoma
    Hoo, Wesley Soo I.
    Higa, Kaylie
    McCormick, Alison A.
    BIOLOGY-BASEL, 2023, 12 (07):
  • [8] Contribution of Epstein-Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
    Vrzalikova, Katerina
    Sunmonu, Taofik
    Reynolds, Gary
    Murray, Paul
    PATHOGENS, 2018, 7 (03):
  • [9] Modulation of Epstein-Barr virus latent membrane protein 1 activity by intrabodies
    Fang, Chih Yeu
    Chiang, Chen Yi
    Pan, Yun Ru
    Tse, Ka Po
    Chang, Yu Sun
    Chang, Hwan You
    INTERVIROLOGY, 2007, 50 (04) : 254 - 263
  • [10] The functional analysis of Epstein-Barr virus latent membrane proteins (LMP1) in patients with lymphoproliferative disorders
    Smirnova K.V.
    Diduk S.V.
    Gurtsevitch V.E.
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2010, 4 (4) : 386 - 394